Article Text
Editorial
Atrial fibrillation: will new drugs and patient choice improve anticoagulation outcomes?
Abstract
The growing epidemic of atrial fibrillation presents major challenges to the healthcare community, both clinical and financial
- AF, atrial fibrillation
- INR, international normalised ratio
- NPT, near patient testing
- atrial fibrillation
- direct thrombin inhibitors
- haemorrhage
- warfarin
- ximelagatran